News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cerus Corporation Announces Third Quarter Financial Results
November 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) today announced financial results for the third quarter ended September 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Cell therapy
Agenus cancer cocktail records 0% response rate, missing midstage goal
April 20, 2026
·
2 min read
·
Gabrielle Masson
IPO tracker
Odyssey tests IPO waters anew after quitting quest last year
April 20, 2026
·
10 min read
·
Tristan Manalac
Layoff Tracker
BMS layoffs hits Lawrenceville hard, adding 200+ to cut count
April 20, 2026
·
49 min read
·
BioSpace Editorial Staff
GLP-1
Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch
April 17, 2026
·
1 min read
·
Tristan Manalac
